The Time Is Right To Purchase Longevity Health Holdings Inc (NASDAQ: XAGE)

During the last session, Longevity Health Holdings Inc (NASDAQ:XAGE)’s traded shares were 2.2 million, with the beta value of the company hitting 0.52. At the end of the trading day, the stock’s price was $0.16, reflecting an intraday loss of -10.51% or -$0.02. The 52-week high for the XAGE share is $2.93, that puts it down -1731.25 from that peak though still a striking 37.5% gain since the share price plummeted to a 52-week low of $0.10. The company’s market capitalization is $4.80M, and the average intraday trading volume over the past 10 days was 31.11 million shares, and the average trade volume was 6.26 million shares over the past three months.

Longevity Health Holdings Inc (NASDAQ:XAGE) trade information

Longevity Health Holdings Inc (XAGE) registered a -10.51% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -10.51% in intraday trading to $0.16, hitting a weekly high. The stock’s 5-day price performance is 24.37%, and it has moved by -28.55% in 30 days. Based on these gigs, the overall price performance for the year is -93.81%. The short interest in Longevity Health Holdings Inc (NASDAQ:XAGE) is 0.12 million shares and it means that shorts have 0.04 day(s) to cover.

XAGE Dividends

Longevity Health Holdings Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Longevity Health Holdings Inc (NASDAQ:XAGE)’s Major holders

Longevity Health Holdings Inc insiders own 20.39% of total outstanding shares while institutional holders control 8.88%, with the float percentage being 11.16%.